Original news and analysis on international IP policy
Global public health experts in charge of exploring ways to finance R&D on diseases endemic in developing countries last week provided a preliminary summary of assessments on proposals provided by various stakeholders. They also made recommendations to establish global mechanisms, including a binding global instrument for R&D and innovation for health.
The World Health Organization will be entering a new phase of its global action plan for influenza vaccines, a WHO representative told reporters today. The goals of the first phase of the programme should be furthered but with more attention given to the local health and policy environment, WHO said.
The Medicines Patent Pool and pharmaceutical company Gilead Sciences today announced a breakthrough licence agreement to allow for the production of key HIV medicines at lower cost and in an easier-to-use formulation, making them more accessible to developing countries. The agreement also opens up the use of treatments for Hepatitis B for the first time.
Concern over non-communicable diseases - traditionally a more developed-country set of problems like diabetes - is energising the international public health policy community. But representatives of the public interest are still grappling with their response.
A diverse team of global experts on public health research and development will meet this week behind closed doors to analyse proposals for ways to fund R&D on diseases afflicting poor populations – and for who should coordinate such global efforts.
A Canadian bill to improve global access to medicines might get another shot in the new Parliament, writes Daniele Dionisio.
At the last session of the World Trade Organization Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council, the Dominican Republic challenged an Australian draft law requiring plain packaging for tobacco products as being incompatible with its WTO obligations, eclipsing other agenda items. The TRIPS Council also addressed other regular agenda items such as related to biodiversity and public health, according to sources.
NEW YORK - The declaration from the United Nations High-Level Meeting on AIDS, which concluded today, set targets for responding to the disease and contained clear references to flexibilities to intellectual property law intended to assure needed medicines can be obtained affordably, according to Brazil's health minister.
This week the United Nations meets in New York with the possibility of finding a way to end the HIV crisis that in the past two decades spread like wildfire and decimated societies in many developing countries, in particular in sub-Saharan Africa.
The World Health Organization Executive Board last week requested more details on the organisation's planned reform and established a consultative process for the reform, according to sources.
After ten days of discussions, country delegates closed the annual World Health Assembly today with the adoption of a set of decisions, one of which is a drastic programme of reforms that is intended to restore the World Health Organization’s central place in public health governance.
Significant budget cuts being approved this week at the World Health Organization will not affect programmes related to intellectual property rights, innovation and public health, a WHO official has told Intellectual Property Watch. In fact, the WHO is intensifying its work in these areas.